ArticleAlzheimer's & dementia (New York, N. Y.)2022

A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease.

Wagner S Brum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.